The Effects of Prenatal Exposure to Pregabalin on the Development of Ventral Midbrain Dopaminergic Neurons.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
01 03 2022
Historique:
received: 25 01 2022
revised: 21 02 2022
accepted: 26 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 12 4 2022
Statut: epublish

Résumé

Pregabalin is widely used as a treatment for multiple neurological disorders; however, it has been reported to have the potential for misuse. Due to a lack of safety studies in pregnancy, pregabalin is considered the last treatment option for various neurological diseases, such as neuropathic pain. Therefore, pregabalin abuse in pregnant women, even at therapeutic doses, may impair fetal development. We used primary mouse embryonic neurons to investigate whether exposure to pregabalin can impair the morphogenesis and differentiation of ventral midbrain neurons. This study focused on ventral midbrain dopaminergic neurons, as they are responsible for cognition, movement, and behavior. The results showed that pregabalin exposure during early brain development induced upregulation of the dopaminergic progenitor genes

Identifiants

pubmed: 35269474
pii: cells11050852
doi: 10.3390/cells11050852
pmc: PMC8909856
pii:
doi:

Substances chimiques

Pregabalin 55JG375S6M

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia
ID : 1-441-133

Références

Nature. 1991 Mar 21;350(6315):230-2
pubmed: 2005978
Drug Des Devel Ther. 2020 Jan 30;14:445-456
pubmed: 32099329
Stem Cell Reports. 2018 Sep 11;11(3):651-664
pubmed: 30146491
Front Mol Neurosci. 2018 May 15;11:156
pubmed: 29867348
BMJ Open. 2019 Jan 21;9(1):e023600
pubmed: 30670513
Ann N Y Acad Sci. 2003 Jun;991:61-8
pubmed: 12846974
PLoS One. 2012;7(2):e30661
pubmed: 22363463
Dev Biol. 2013 Jul 15;379(2):123-38
pubmed: 23603197
J Neurosci. 2006 Apr 26;26(17):4567-76
pubmed: 16641236
N Engl J Med. 2017 Aug 3;377(5):411-414
pubmed: 28767350
PLoS One. 2019 Aug 5;14(8):e0214180
pubmed: 31381574
Neurol Res. 2013 Nov;35(9):948-58
pubmed: 23816319
Pain. 2005 Jun;115(3):254-263
pubmed: 15911152
BMJ. 2013 Nov 08;347:f6747
pubmed: 24212252
J Neural Transm (Vienna). 2009 Mar;116(3):333-8
pubmed: 19189040
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2360-5
pubmed: 23341612
J Clin Psychiatry. 2018 Oct 2;79(5):
pubmed: 30289631
Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):E4387-96
pubmed: 27407143
J Clin Invest. 2014 Jul;124(7):3107-20
pubmed: 24911152
J Mol Cell Biol. 2014 Feb;6(1):54-63
pubmed: 24334258
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003021
pubmed: 19370579
Curr Neuropharmacol. 2014 Jan;12(1):44-56
pubmed: 24533015
Neurology. 2017 May 23;88(21):2020-2025
pubmed: 28446648
Front Psychol. 2016 Nov 24;7:1865
pubmed: 27933030
Sci Rep. 2021 May 19;11(1):10577
pubmed: 34011976
Clin Ther. 2007 Jan;29(1):26-48
pubmed: 17379045
PLoS One. 2013 Sep 16;8(9):e74049
pubmed: 24066094
Gan To Kagaku Ryoho. 2012 Feb;39(2):277-80
pubmed: 22333643
Sci Rep. 2017 Aug 24;7(1):9368
pubmed: 28839197
Int J Clin Pract. 2014 Jan;68(1):104-10
pubmed: 23815622
Cochrane Database Syst Rev. 2019 Jan 23;1:CD007076
pubmed: 30673120
Neurotoxicology. 2021 Mar;83:146-155
pubmed: 33515658
J Neurosci. 2020 Jan 22;40(4):932-941
pubmed: 31811028
Trends Genet. 2000 Feb;16(2):75-83
pubmed: 10652534
Front Neurosci. 2011 Dec 20;5:135
pubmed: 22194714
Epilepsia. 2004;45 Suppl 6:13-8
pubmed: 15315511
Neurology. 2017 Jan 3;88(1):e5-e7
pubmed: 28025404
Nature. 2011 Jul 03;476(7359):224-7
pubmed: 21725324
Cells. 2020 Jun 18;9(6):
pubmed: 32570916
J Neurochem. 2009 Dec;111(5):1202-12
pubmed: 19780901
J Neurosci. 2009 Apr 22;29(16):5170-82
pubmed: 19386913
Sci Rep. 2020 Apr 14;10(1):6272
pubmed: 32286346
Naunyn Schmiedebergs Arch Pharmacol. 2020 Sep;393(9):1635-1648
pubmed: 32377769
Prog Neurobiol. 2008 May;85(1):75-93
pubmed: 18304718

Auteurs

Walaa F Alsanie (WF)

Department of Clinical Laboratories Sciences, The Faculty of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Centre of Biomedical Sciences Research (CBSR), Deanship of Scientific Research, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

Majid Alhomrani (M)

Department of Clinical Laboratories Sciences, The Faculty of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Centre of Biomedical Sciences Research (CBSR), Deanship of Scientific Research, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

Ahmed Gaber (A)

Centre of Biomedical Sciences Research (CBSR), Deanship of Scientific Research, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Department of Biology, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

Hamza Habeeballah (H)

Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences in Rabigh, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Heba A Alkhatabi (HA)

Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Center of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University, Jeddah 21589, Saudi Arabia.
King Fahd Medical Research Centre, Hematology Research Unit, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Raed I Felimban (RI)

Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Center of Innovation in Personalized Medicine (CIPM), 3D Bioprinting Unit, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Sherin Abdelrahman (S)

Laboratory for Nanomedicine, Division of Biological and Environmental Science and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi Arabia.

Charlotte A E Hauser (CAE)

Laboratory for Nanomedicine, Division of Biological and Environmental Science and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi Arabia.
Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology, Thuwal 23955, Saudi Arabia.

Adeel G Chaudhary (AG)

Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Center of Innovation in Personalized Medicine (CIPM), 3D Bioprinting Unit, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Abdulhakeem S Alamri (AS)

Department of Clinical Laboratories Sciences, The Faculty of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Centre of Biomedical Sciences Research (CBSR), Deanship of Scientific Research, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

Bassem M Raafat (BM)

Department of Radiological Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

Abdulwahab Alamri (A)

Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail 55211, Saudi Arabia.

Sirajudheen Anwar (S)

Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail 55211, Saudi Arabia.

Khaled A Alswat (KA)

Department of Internal Medicine, School of Medicine, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

Yusuf S Althobaiti (YS)

Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Addiction and Neuroscience Research Unit, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

Yousif A Asiri (YA)

Department of Clinical Pharmacy, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH